Decisionexus and Captario Announce Strategic Collaboration Agreement

Tampa, Florida, US / Gothenburg, Sweden – June 23, 2025

Decisionexus LLC is pleased to announce a new strategic agreement with Captario, a leading innovator in portfolio analysis for the pharmaceutical industry.

Founded and led by former senior executives from leading global pharma companies, Decisionexus brings a deep understanding of the complex realities faced by drug development organizations. With this agreement, Decisionexus will take a leading role in customer engagements, helping clients fully leverage Captario SUM®, an AI-powered platform for Strategic Uncertainty Management. By enabling real-time Monte Carlo simulations, AI- enhanced predictive modeling, and dynamic scenario planning, Captario SUM® allows users to make faster, smarter, and more transparent decisions across the entire drug development lifecycle.

This partnership brings together Captario’s advanced technology with Decisionexus’s deep expertise in decision analysis, stakeholder alignment, and strategic facilitation. Together, the firms will deliver tailored, high-impact engagements that accelerate value creation and improve outcomes for clients navigating complex, uncertain environments.

“We’re excited to collaborate with Captario and its world class platform to deliver even greater impact for clients,” said Terrence Karner, Principal at Decisionexus. “This agreement enables us to help organizations to drive strategic agility, reduce decision latency, and maximize portfolio value.”

For more information, please contact:

Terrence Karner
Principal, Decisionexus LLC terrence.karner@decisionexusllc.com
+1 847-338-9791

Magnus Ytterstad
Head of Customer Success & Portfolio Analytics, Captario magnus.ytterstad@captario.com
+1 551 755 1239